Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine
Completed · Not applicable
Conditions studied: Ovarian Cancer, Peritoneal Primary Cancer, Fallopian Tube Cancer
In brief
RATIONALE: Chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Hypnosis, massage therapy, and healing touch may improve the quality of life of patients who are undergoing chemotherapy. PURPOSE: This randomized clinical trial is studying how well giving hypnosis, massage therapy and healing touch changes outcomes in women receiving chemotherapy for newly diagnosed epithelial ovarian, fallopian tube or peritoneal cavity cancer.
Key facts
- Study ID
- NCT00293293
- Run by
- Masonic Cancer Center, University of Minnesota
- People needed
- 43
- Starts
- 2005-05-01
- Expected to finish
- 2010-01-01
- Last updated by the study team
- 2017-12-28
Who can join
Age: any. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Newly diagnosed epithelial ovarian, primary peritoneal or fallopian tube cancer, any pathologic type or stage, who will receive 6 cycles of chemotherapy.
- Patients must have signed an informed consent
You may not qualify if…
- Previous cancer other than skin cancer
- Previous chemotherapy experience
- Active substance abuse
- Schizophrenia
- Pregnant or lactating
Where it is running
- Masonic Cancer Center at University of Minnesota — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.